Equities

Penta Valent Tbk PT

PEVE:JKT

Penta Valent Tbk PT

Actions
Consumer DiscretionaryConsumer Discretionary
  • Price (IDR)270.00
  • Today's Change-6.00 / -2.17%
  • Shares traded1.63m
  • 1 Year change+63.64%
  • Beta--
Data delayed at least 10 minutes, as of May 31 2024 10:09 BST.
More ▼
Improved Notifications for Markets Data Alerts
Improved Notifications for Markets Data Alerts
Want push notifications sent directly to your devices for equity price changes and breaking news stories? Let us know here.
 
Existing alertsView our existing alerts
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

PT Penta Valent Tbk is engaged in the distribution of pharmaceutical products, medical equipment and consumer products. The pharmaceutical products or medicines and medical devices distributed by the Company are divided into several types, including ethical products, which are medicines sold in limited quantities and require a doctor’s prescription; Over The Counter products, which are medicines sold freely; Medical Devices, which are medical supporting devices such as blood pressure monitors, nebulizer, kateter, and others; Reagents, which are reaction materials such as blood sugar tests, pregnancy tests, or rapid tests for Covid-19, drug tests, and others; as well as Food Supplements. Its distribution of consumer goods, which is divided into two types of products, namely Cosmetics: products for beauty and skin care, including makeup, perfume, skin nutrition, and others; and Toiletries: products for daily cleanliness and hygiene such as soap, shampoo, toothpaste, lotion, and other.

  • Revenue in IDR (TTM)2.66tn
  • Net income in IDR40.79bn
  • Incorporated2015
  • Employees--
  • Location
    Penta Valent Tbk PTKedoya Utara Kebon JerukJI Kedoya raya no 33JAKARTA BARAT 11520IndonesiaIDN
  • Phone+62 215673891
  • Websitehttps://www.pentavalent.co.id/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Multi Indocitra Tbk PT1.09tn32.08bn288.00bn404.008.860.3175.310.263354.1954.191,847.861,513.980.85711.605.222,762,183,000.002.512.853.704.0146.0650.652.933.690.76172.710.2496--11.4911.24-27.970.8175-21.71--
Exceed World Inc373.03bn-21.54bn343.27bn41.00--1.33--0.9202-0.0405-0.04050.7020.48730.895310.42424.59559,890.50-5.174.14-7.276.1750.1948.99-5.774.023.01-622.740.0019---25.27-5.76-113.33---31.13--
Liberta Co Ltd763.56bn-727.62m368.13bn118.00--2.4524.590.4821-2.34-2.342,487.28482.671.202.677.6562,643,520.00-0.10683.75-0.21696.4238.2441.81-0.08912.370.82473.150.694835.676.779.76-2.77-12.8523.12--
Medical Developments International Ltd362.11bn-207.70bn396.55bn68.00--0.4846--1.10-0.2226-0.22260.38820.8770.33481.016.18---19.20-6.67-22.18-7.4369.6469.90-57.36-23.551.93--0.0311--47.3713.1254.79---6.41--
Delko SA3.72tn69.14bn412.51bn1.16k5.970.64263.040.11081.401.4075.4813.012.650.168011.04--4.93--8.46--98.30--1.86--0.7361849.720.3958--------------
Penta Valent Tbk PT2.66tn40.79bn476.72bn--11.561.9710.250.179423.3623.361,525.15137.393.068.956.37--4.69--15.53--12.01--1.54--0.925811.070.2678--15.71--53.62------
Rhone Ma Holdings Bhd711.69bn42.02bn504.07bn--16.340.88938.350.70830.04040.04040.68420.74220.94242.934.98--6.266.157.477.3826.4028.116.646.852.9113.360.14432.112.418.46-5.163.72-27.03-7.79
EZZ Life Science Holdings Ltd472.60bn37.55bn511.37bn--13.082.9712.491.080.08140.08141.020.35822.489.6313.51--19.6921.2224.8529.1974.7755.317.949.113.61293.270.019513.08147.26--176.57------
Microalliance Group Inc371.86bn159.53bn595.07bn30.004.441.203.681.600.01350.01350.03250.05010.76310.486912.65762,790.3032.74--35.89--68.46--42.90--12.67--0.00--3,030.68--3,074.43------
COSMO BIO COMPANY, LIMITED976.66bn42.14bn628.48bn155.0014.380.659310.710.643569.9469.941,620.671,525.810.84846.092.8761,000,000.003.805.624.546.7233.8237.404.486.235.15--0.002133.53-2.235.16-14.5111.20-8.0316.47
Data as of May 31 2024. Currency figures normalised to Penta Valent Tbk PT's reporting currency: Indonesian Rupiah IDR
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.